Company Profile

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE20746.95190.95 (+0.93 % )
PREV CLOSE (Rs.) 20556.00
OPEN PRICE (Rs.) 20600.05
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1925
TODAY'S LOW / HIGH (Rs.)20356.55 21352.85
52 WK LOW / HIGH (Rs.)13970.1 23902.3
NSE20686.10 112.35 (+0.55 % )
PREV CLOSE(Rs.) 20573.75
OPEN PRICE (Rs.) 20639.00
BID PRICE (QTY) 20686.10 (2 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 43185
TODAY'S LOW / HIGH(Rs.) 20328.90 21366.00
52 WK LOW / HIGH (Rs.)13959.8 23934.45

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 1.33
TTM EPS (Rs.) 332.29
P/E Ratio 62.44
Book Value (Rs.) 1295.88
Face Value (Rs.) 10
MCap (Rs. in Mn) 440858.21
Price/Earning (TTM) 57.56
Price/Sales (TTM) 9.88
Price/Book (MRQ) 16.01
PAT Margin (%) 16.03
ROCE (%) 37.52
Incorporation Year : 1944

Management Info :

Munir Shaikh - Chairman Anil Joseph - Managing Director

Registered Office :

Address : Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone : 022-50461000/2000/1119/1117/1116/6797 8888

Website : www.abbott.co.in

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS More
06Oct10-06-2021$Abbott India informs about certificate Abbott India informs about c

In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, Abbott India has informed that it enclosed certificate issued by KFin Technologies, Registrar and Share Agent of the Company for the second quarter ended September 30, 2021.

The above information is a part of company’s filings submitted to BSE.

In terms of Regulation 74(5) of the Securities and Exchange Boa..
31Aug08-31-2021$Abbott introduces single-dose formulation of carbetocin in India Abbott introduces single-dos

Abbott has launched room-temperature-stable, single-dose formulation of carbetocin in India to help in the prevention of postpartum haemorrhage (PPH).

PPH refers to excessive blood loss of 500 ml or more after vaginal delivery and 1,000 ml or more after a caesarean procedure, within 24 hours of childbirth. Although preventable, PPH is associated with almost 20 per cent maternal mortality in the country.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott has launched room-temperature-stable, single-dose formul..
31Aug08-31-2021$Abbott trades in green on introducing single-dose formulation of carbetocin in India Abbott trades in green on in

Abbott India is currently trading at Rs. 19317.70, up by 232.80 points or 1.22% from its previous closing of Rs. 19084.90 on the BSE.

The scrip opened at Rs. 19276.20 and has touched a high and low of Rs. 19388.00 and Rs. 19070.10 respectively. So far 446 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 19983.70 on 02-Aug-2021 and a 52 week low of Rs. 13970.10 on 02-Feb-2021.

Last one week high and low of the scrip stood at Rs. 19388.00 and Rs. 18757.70 respectively. The current market cap of the company is Rs. 41014.77 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 6.99% and 18.03% respectively.

Abbott has launched room-temperature-stable, single-dose formulation of carbetocin in India to help in the prevention of postpartum haemorrhage (PPH).

PPH refers to excessive blood loss of 500 ml or more after vaginal delivery and 1,000 ml or more after a caesarean procedure, within 24 hours of childbirth. Although preventable, PPH is associated with almost 20 per cent maternal mortality in the country.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.


AbbottIndiais currently trading at Rs. 19317.70, up by 232.80 p..
28Jul07-28-2021$ Board Meeting Intimation for Approving The Text Of Unaudited Financial Results Of The Company For The First Quarter Ended On June 30, 2021 Board Meeting Intimation fo
ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2021 ,inter alia, to consider and approve the text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2021. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2019, the Trading Window of the Company remains closed from Wednesday, June 30, 2021 to Sunday, August 8, 2021 (both days inclusive). This is for your information and records.
ABBOTT INDIA LTD.has informed BSE that the meeting of the Board..
13Jul07-13-2021$Abbott surges on launching COVID-19 home test kit in India Abbott surges on launching C

Abbott India is currently trading at Rs. 17388.20, up by 99.05 points or 0.57% from its previous closing of Rs. 17289.15 on the BSE.

The scrip opened at Rs. 17337.85 and has touched a high and low of Rs. 17388.20 and Rs. 17225.05 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 17500.00 on 12-Jul-2021 and a 52 week low of Rs. 13970.10 on 02-Feb-2021.

Last one week high and low of the scrip stood at Rs. 17500.00 and Rs. 16780.00 respectively. The current market cap of the company is Rs. 36657.38 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 6.54% and 18.47% respectively.

Abbott has launched COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms at a price of Rs 325 for a single test kit pack.

The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott India is currently trading at Rs. 17388.20, up by 99.05..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit1957.66906.9
Gross Profit 2635.9 9259.5
Operating Profit 2843.610023.6
Net Sales 12178.343100.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Ajanta Pharma (BSE)
 2215.40 (2.45%)
M.Cap ( in Cr)
19171.13
Sanofi India (BSE)
 8117.95 (0.35%)
M.Cap ( in Cr)
18696.14
Mercury Laboratories (BSE)
 718.00 (3.16%)
M.Cap ( in Cr)
86.16
Suven Pharma (BSE)
 533.95 (1.75%)
M.Cap ( in Cr)
13592.50
Coral Laboratories (BSE)
 373.00 (1.97%)
M.Cap ( in Cr)
133.26
Shareholding Pattern More
PROMOTERS 74.99 %
MUTUAL FUNDS/UTI 3.64 %
NON-INSTITUTION 17.89 %
FI/BANKS/INSURANCE 0.66 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes